{"ticker": {"uuid": "b59f7474-5781-4c3e-9e55-1b25b55ed233", "symbol": "ALM", "name": "Almirall, S.A.", "exchange": "MCE", "country": "ES", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology", "summary": "The collaboration will leverage CrystalO's ion channel small-molecule drug discovery platform and Almirall's expertise in skin science to jointly advance an innovative small-molecule program in medical dermatology. CrystalO will conduct candidate discovery, optimization, IND-enabling studies and early clinical development to deliver clinical proof of concept (POC), while Almirall will lead subsequent global development, manufacturing and commercialization holding exclusive rights outside mainland China. The agreement further expands Almirall's innovation footprint in China, based on the compan", "url": "https://finance.yahoo.com/healthcare/articles/almirall-enters-collaboration-crystalo-discovery-060000433.html", "source_link": "https://finance.yahoo.com/healthcare/articles/almirall-enters-collaboration-crystalo-discovery-060000433.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-10T06:00:00+00:00", "published_display": "10 Aug 2026 06:00", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "positive", "sentiment_pct": 58, "tone_signals": ["Positive financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.057123, "evidence_share": 92.1, "evidence_share_display": "92.1", "freshness_pct": 60.1, "age_days": 3.7, "influence_label": "High", "duplicate_count": 2, "topics": ["COLLABORATION", "Collaboration", "DRUG-DISCOVERY", "Drug Discovery", "MEDICAL-DERMATOLOGY", "Medical Dermatology"], "evidence_basis": "", "score_included": true}, {"title": "Almirall, S.A.: Target Price Consensus and Analysts Recommendations | ALM | ES0157097017", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Almirall%2C+S.A.%3A+Target+Price+Consensus+and+Analysts+Recommendations+%7C+ALM+%7C+ES0157097017%22+%22marketscreener.com%22", "source_link_is_lookup": true, "source_name": "marketscreener.com", "published_at": "2026-08-02T01:27:03.974375+00:00", "published_display": "02 Aug 2026 01:27", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.004883, "evidence_share": 7.9, "evidence_share_display": "7.9", "freshness_pct": 6.5, "age_days": 11.9, "influence_label": "Medium", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}], "by_tier": {"direct": [{"title": "Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology", "summary": "The collaboration will leverage CrystalO's ion channel small-molecule drug discovery platform and Almirall's expertise in skin science to jointly advance an innovative small-molecule program in medical dermatology. CrystalO will conduct candidate discovery, optimization, IND-enabling studies and early clinical development to deliver clinical proof of concept (POC), while Almirall will lead subsequent global development, manufacturing and commercialization holding exclusive rights outside mainland China. The agreement further expands Almirall's innovation footprint in China, based on the compan", "url": "https://finance.yahoo.com/healthcare/articles/almirall-enters-collaboration-crystalo-discovery-060000433.html", "source_link": "https://finance.yahoo.com/healthcare/articles/almirall-enters-collaboration-crystalo-discovery-060000433.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-10T06:00:00+00:00", "published_display": "10 Aug 2026 06:00", "provider": "eodhd", "providers": ["archive", "eodhd"], "provider_symbol": "ALM.MC", "provider_symbols": ["ALM.ARCHIVE", "ALM.MC", "ALM.US", "E2Z.F", "LBTSF.US"], "target_provider_symbol": "ALM.MC", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "b840374ca56d49eb5902dcbe74c64a59299e5e97dcbf8778c42598947e356716", "target_scope": "Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology The collaboration will leverage CrystalO's ion channel small-molecule drug discovery platform and Almirall's expertise in skin science to jointly advance an innovative small-molecule program in medical dermatology. CrystalO will conduct candidate discovery, optimization, IND-enabling studies and early clinical development to deliver clinical proof of concept (POC), while Almirall will lead subsequent global development, manufacturing and commercialization holding exclusive rights outside mainland China. The agreement further expands Almirall's innovation footprint in China, based on the compan", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.525, "provider_directional_mass": 0.1449, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 58, "tone_signals": ["Positive financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.057123, "evidence_share": 92.1, "evidence_share_display": "92.1", "freshness_pct": 60.1, "age_days": 3.7, "influence_label": "High", "duplicate_count": 2, "topics": ["COLLABORATION", "Collaboration", "DRUG-DISCOVERY", "Drug Discovery", "MEDICAL-DERMATOLOGY", "Medical Dermatology"], "evidence_basis": "", "score_included": true}, {"title": "Almirall, S.A.: Target Price Consensus and Analysts Recommendations | ALM | ES0157097017", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Almirall%2C+S.A.%3A+Target+Price+Consensus+and+Analysts+Recommendations+%7C+ALM+%7C+ES0157097017%22+%22marketscreener.com%22", "source_link_is_lookup": true, "source_name": "marketscreener.com", "published_at": "2026-08-02T01:27:03.974375+00:00", "published_display": "02 Aug 2026 01:27", "provider": "archive", "providers": ["archive"], "provider_symbol": "", "provider_symbols": ["ALM.ARCHIVE"], "target_provider_symbol": "ALM.ARCHIVE", "cross_listing": false, "source_names": ["marketscreener.com"], "source_kind": "publisher", "story_key": "9e506793d2b21649a51b972a655c2a1db57273b13ef31d53f7b3992af4c1e68c", "target_scope": "Almirall, S.A.: Target Price Consensus and Analysts Recommendations | ALM | ES0157097017", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.004883, "evidence_share": 7.9, "evidence_share_display": "7.9", "freshness_pct": 6.5, "age_days": 11.9, "influence_label": "Medium", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}], "industry": [], "sector": []}, "total_fetched": 3, "total_unique": 2, "total_relevant": 2, "total_matched": 2, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 1}, "provider_relevant_counts": {"eodhd": 1}, "provider_rejected_counts": {"eodhd": 0}, "provider_errors": {}, "raw_articles": 3, "unique_stories": 2, "duplicates_removed": 1, "relevant_stories": 2, "matched_archive_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 1, "archive_articles": 1, "eodhd": {"configured": true, "status": "healthy", "calls_used": 585, "call_budget": 10000, "budget_used_pct": 5.9, "requests_made": 117, "last_success_at": "2026-08-13T22:06:11.057277+00:00", "newest_seen_at": "2026-08-13T22:01:52+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 4098, "unmapped_mentions": 1878}, "status": "healthy"}, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 1, "score": 50, "raw_score": 58, "total": 2, "evidence_count": 2, "effective_articles": 1.17, "information_mass": 0.062, "direct_story_count": 2, "direct_source_count": 2, "industry_story_count": 0, "sector_story_count": 0, "story_count": 2, "source_count": 2, "source_concentration": 0.8549, "direct_share": 80, "dispersion": 2, "confidence": 22, "evidence_status": "provisional", "score_version": "evidence-v9", "window_days": 30, "weighting_method": "event-aware exponential freshness decay", "newest_article_at": "2026-08-10T06:00:00+00:00", "label": "Early balanced news score", "tone": "neutral"}, "classifier": {"primary_event": "analyst", "primary_label": "Analyst action", "confidence": 58, "events": [{"event": "analyst", "label": "Analyst action", "weight": 0.6, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 1}, "provider_relevant_counts": {"eodhd": 1}, "provider_rejected_counts": {"eodhd": 0}, "provider_errors": {}, "raw_articles": 3, "unique_stories": 2, "duplicates_removed": 1, "relevant_stories": 2, "matched_archive_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 1, "archive_articles": 1, "eodhd": {"configured": true, "status": "healthy", "calls_used": 585, "call_budget": 10000, "budget_used_pct": 5.9, "requests_made": 117, "last_success_at": "2026-08-13T22:06:11.057277+00:00", "newest_seen_at": "2026-08-13T22:01:52+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 4098, "unmapped_mentions": 1878}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 10.84, "latest_week": "2026-08-07", "one_week_move": -2.5, "four_week_move": -3.6, "twelve_week_move": -4.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.070264, "market_dynamics_buy_signal": false, "relative_strength": -22.187103, "fair_value_gap": 10.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 52.8961, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.5% over one week, -3.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Early company-news score", "tone": "neutral", "classification": "provisional", "summary": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.", "confidence": 22, "badges": ["Provisional evidence"], "opportunities": [], "risks": [], "event_label": "Analyst action", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Early balanced news score"}, {"label": "Evidence confidence", "value": "22/100", "tone": "neutral", "text": "1.17 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Early company-news score", "tone": "neutral", "text": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal."}, {"label": "Primary event", "value": "Analyst action", "tone": "neutral", "text": "58/100 evidence concentration around this catalyst."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "80% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "2/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.5% over one week, -3.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology"}], "updated_at": "2026-08-13T22:09:43.814804+00:00", "detail_intelligence": {"headline": "Early balanced news score", "summary": "2 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.", "status": "provisional", "metrics": [{"label": "News score", "value": 50, "display": "50", "tone": "neutral", "note": "Early balanced news score"}, {"label": "Confidence", "value": 22, "display": "22", "tone": "negative", "note": "thin evidence"}, {"label": "Company news", "value": 80, "display": "80%", "tone": "positive", "note": "2 company stories"}, {"label": "Story agreement", "value": 98, "display": "98", "tone": "positive", "note": "2/100 difference"}], "confidence_drivers": [{"label": "Amount of evidence", "value": 1, "note": "0.062 after freshness weighting"}, {"label": "Source breadth", "value": 40, "note": "2 independent publishers"}, {"label": "Company relevance", "value": 80, "note": "share tied directly to this company"}, {"label": "Freshness", "value": 50, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 98, "note": "how closely stories agree"}, {"label": "Publisher mix", "value": 15, "note": "less reliance on one publisher"}], "freshness": 50, "source_independence": 15, "timeline": [{"date": "2026-07-15", "label": "15 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-16", "label": "16 Jul", "count": 0, "score": null, "tone": "neutral", "x": 73.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-17", "label": "17 Jul", "count": 0, "score": null, "tone": "neutral", "x": 105.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-18", "label": "18 Jul", "count": 0, "score": null, "tone": "neutral", "x": 136.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-19", "label": "19 Jul", "count": 0, "score": null, "tone": "neutral", "x": 168.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-20", "label": "20 Jul", "count": 0, "score": null, "tone": "neutral", "x": 199.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-21", "label": "21 Jul", "count": 0, "score": null, "tone": "neutral", "x": 231.5, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-22", "label": "22 Jul", "count": 0, "score": null, "tone": "neutral", "x": 263.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-23", "label": "23 Jul", "count": 0, "score": null, "tone": "neutral", "x": 294.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 326.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 357.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 389.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 421.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 452.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 484.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 515.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 547.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 579.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 1, "score": 50, "tone": "neutral", "x": 610.6, "y": 135.0, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 642.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 673.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 705.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 736.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 0, "score": null, "tone": "neutral", "x": 768.5, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 800.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 831.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 1, "score": 58, "tone": "positive", "x": 863.2, "y": 120.4, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 0, "score": null, "tone": "neutral", "x": 894.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 926.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "610.6,135.0 863.2,120.4", "timeline_has_signal": true, "timeline_start": "15 Jul", "timeline_mid": "30 Jul", "timeline_end": "13 Aug", "momentum": {"label": "Cooling", "tone": "neutral", "recent_score": null, "prior_score": 58, "delta": null, "recent_count": 0, "prior_count": 1, "volume_delta": -1, "reliable": false, "reliability_note": "Thin comparison; direction is not yet confirmed"}, "early_change": {"label": "No new story in 24 hours", "tone": "neutral", "latest_score": null, "baseline_score": 58, "delta": null, "latest_count": 0, "baseline_count": 1, "confirmed": false, "note": "A comparison needs current and earlier-week company news"}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 0, "share": 0}, {"label": "4 to 7 days", "count": 1, "share": 50}, {"label": "8 to 14 days", "count": 1, "share": 50}, {"label": "15 to 21 days", "count": 0, "share": 0}, {"label": "22 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 1, "share": 50, "score": 58, "tone": "positive"}, {"label": "marketscreener.com", "count": 1, "share": 50, "score": 50, "tone": "neutral"}], "event_profile": [{"label": "Earnings", "count": 1, "share": 50, "score": 58, "tone": "positive"}, {"label": "Analyst action", "count": 1, "share": 50, "score": 50, "tone": "neutral"}], "topics": [{"label": "Medical Dermatology", "count": 1, "share": 50}, {"label": "MEDICAL-DERMATOLOGY", "count": 1, "share": 50}, {"label": "Drug Discovery", "count": 1, "share": 50}, {"label": "DRUG-DISCOVERY", "count": 1, "share": 50}, {"label": "Collaboration", "count": 1, "share": 50}, {"label": "COLLABORATION", "count": 1, "share": 50}], "supporting": [{"label": "Direct evidence", "text": "2 current stories are mapped specifically to ALM."}], "tempering": [{"label": "Source breadth", "text": "Only 2 publishers currently contribute to the measured read."}, {"label": "Too little evidence", "text": "The stories agree, but freshness-weighted evidence is only 0.062."}, {"label": "Confidence", "text": "Confidence is 22/100, below the threshold for a firm score."}], "supporting_heading": "What supports the score", "tempering_heading": "What limits the score", "latest_observation": {"title": "Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology", "summary": "The collaboration will leverage CrystalO's ion channel small-molecule drug discovery platform and Almirall's expertise in skin science to jointly advance an innovative small-molecule program in medical dermatology. CrystalO will conduct candidate discovery, optimization, IND-enabling studies and early clinical development to deliver clinical proof of concept (POC), while Almirall will lead subsequent global development, manufacturing and commercialization holding exclusive rights outside mainland China. The agreement further expands Almirall's innovation footprint in China, based on the compan", "url": "https://finance.yahoo.com/healthcare/articles/almirall-enters-collaboration-crystalo-discovery-060000433.html", "source_link": "https://finance.yahoo.com/healthcare/articles/almirall-enters-collaboration-crystalo-discovery-060000433.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-10T06:00:00+00:00", "published_display": "10 Aug 2026 06:00", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "positive", "sentiment_pct": 58, "tone_signals": ["Positive financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.057123, "evidence_share": 92.1, "evidence_share_display": "92.1", "freshness_pct": 60.1, "age_days": 3.7, "influence_label": "High", "duplicate_count": 2, "topics": ["COLLABORATION", "Collaboration", "DRUG-DISCOVERY", "Drug Discovery", "MEDICAL-DERMATOLOGY", "Medical Dermatology"], "evidence_basis": "", "score_included": true}, "article_count": 2, "updated_at": "2026-08-13T22:09:43.814804+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 57.0, "label": "13 Feb 2026", "close": 13.18, "index": 100.0}, {"x": 78.4, "y": 55.8, "label": "20 Feb 2026", "close": 13.2, "index": 100.1}, {"x": 114.9, "y": 87.0, "label": "27 Feb 2026", "close": 12.67, "index": 96.1}, {"x": 151.3, "y": 139.1, "label": "06 Mar 2026", "close": 11.79, "index": 89.4}, {"x": 187.7, "y": 175.0, "label": "13 Mar 2026", "close": 11.18, "index": 84.8}, {"x": 224.2, "y": 171.5, "label": "20 Mar 2026", "close": 11.24, "index": 85.2}, {"x": 260.6, "y": 132.2, "label": "27 Mar 2026", "close": 11.91, "index": 90.3}, {"x": 297.0, "y": 119.4, "label": "03 Apr 2026", "close": 12.12, "index": 91.9}, {"x": 333.5, "y": 80.1, "label": "10 Apr 2026", "close": 12.79, "index": 97.0}, {"x": 369.9, "y": 92.8, "label": "17 Apr 2026", "close": 12.57, "index": 95.4}, {"x": 406.3, "y": 96.3, "label": "24 Apr 2026", "close": 12.52, "index": 94.9}, {"x": 442.8, "y": 104.4, "label": "01 May 2026", "close": 12.38, "index": 93.9}, {"x": 479.2, "y": 140.3, "label": "08 May 2026", "close": 11.77, "index": 89.3}, {"x": 515.6, "y": 166.6, "label": "15 May 2026", "close": 11.32, "index": 85.9}, {"x": 552.0, "y": 150.1, "label": "22 May 2026", "close": 11.6, "index": 88.0}, {"x": 588.5, "y": 163.0, "label": "29 May 2026", "close": 11.38, "index": 86.3}, {"x": 624.9, "y": 171.3, "label": "05 Jun 2026", "close": 11.24, "index": 85.3}, {"x": 661.3, "y": 165.4, "label": "12 Jun 2026", "close": 11.34, "index": 86.0}, {"x": 697.8, "y": 178.3, "label": "19 Jun 2026", "close": 11.12, "index": 84.3}, {"x": 734.2, "y": 168.9, "label": "26 Jun 2026", "close": 11.28, "index": 85.6}, {"x": 770.6, "y": 161.9, "label": "03 Jul 2026", "close": 11.4, "index": 86.5}, {"x": 807.1, "y": 171.3, "label": "10 Jul 2026", "close": 11.24, "index": 85.3}, {"x": 843.5, "y": 204.2, "label": "17 Jul 2026", "close": 10.68, "index": 81.0}, {"x": 879.9, "y": 173.6, "label": "24 Jul 2026", "close": 11.2, "index": 84.9}, {"x": 916.4, "y": 178.3, "label": "31 Jul 2026", "close": 11.12, "index": 84.3}, {"x": 952.8, "y": 194.8, "label": "07 Aug 2026", "close": 10.84, "index": 82.2}], "sentiment_points": [{"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 50, "confidence": 18, "stories": 1, "close": 10.84, "price_change": -2.5, "x": 958.0, "y": 130.0, "show_label": true, "label_y": 120.0}], "price_path": "42.0,57.0 78.4,55.8 114.9,87.0 151.3,139.1 187.7,175.0 224.2,171.5 260.6,132.2 297.0,119.4 333.5,80.1 369.9,92.8 406.3,96.3 442.8,104.4 479.2,140.3 515.6,166.6 552.0,150.1 588.5,163.0 624.9,171.3 661.3,165.4 697.8,178.3 734.2,168.9 770.6,161.9 807.1,171.3 843.5,204.2 879.9,173.6 916.4,178.3 952.8,194.8", "sentiment_path": "958.0,130.0", "score_version": "evidence-v9", "price_change": -17.8, "sentiment_change": null, "recent_pairs": [{"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 50, "confidence": 18, "stories": 1, "close": 10.84, "price_change": -2.5, "x": 958.0, "y": 130.0, "show_label": true, "label_y": 120.0}], "reconstructed": true, "latest_close": 10.84, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug", "live_score_version": "evidence-v9", "comparable_to_live": true}, "sentiment_history": [{"label": "02 Aug 23:59", "short_label": "02 Aug", "collected_at": "2026-08-02T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 2, "score_change_display": "+2", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 2, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "13 Aug 22:09", "short_label": "13 Aug", "collected_at": "2026-08-13T22:09:43.822324+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -6, "article_change": 0, "tone": "neutral", "height": 4, "articles": 2, "confidence": 21, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}], "sentiment_history_insight": {"available": true, "series_version": "evidence-v9", "live_version": "evidence-v9", "comparable_to_live": true, "reconstructed": true, "observations": 3, "span_label": "11 days", "first_score": 50, "latest_score": 51, "net_change": 1, "net_change_display": "+1", "direction": "Broadly stable", "high_score": 52, "low_score": 50, "latest_confidence": 21, "confidence_change": -5, "latest_articles": 2, "article_change": 1, "latest_label": "13 Aug 22:09", "latest_evidence_label": "Provisional", "chart_rows": [{"label": "02 Aug 23:59", "short_label": "02 Aug", "collected_at": "2026-08-02T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 42.0, "y": 135.0}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 2, "score_change_display": "+2", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 2, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 500.0, "y": 131.4}, {"label": "13 Aug 22:09", "short_label": "13 Aug", "collected_at": "2026-08-13T22:09:43.822324+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -6, "article_change": 0, "tone": "neutral", "height": 4, "articles": 2, "confidence": 21, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 958.0, "y": 133.2}], "chart_points": "42.0,135.0 500.0,131.4 958.0,133.2", "changes": [{"label": "13 Aug 22:09", "short_label": "13 Aug", "collected_at": "2026-08-13T22:09:43.822324+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -6, "article_change": 0, "tone": "neutral", "height": 4, "articles": 2, "confidence": 21, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 2, "score_change_display": "+2", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 2, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "02 Aug 23:59", "short_label": "02 Aug", "collected_at": "2026-08-02T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}]}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}